These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5330245)

  • 21. Quantitative morphometric studies of pancreatic islets obtained from tolbutamide-treated rats.
    Yorde DE; Kalkhoff RK
    J Histochem Cytochem; 1986 Sep; 34(9):1195-200. PubMed ID: 3525667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolbutamide as mimic of glucose on beta-cell electrical activity. ATP-sensitive K+ channels as common pathway for both stimuli.
    Cook DL; Ikeuchi M
    Diabetes; 1989 Apr; 38(4):416-21. PubMed ID: 2647550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative studies on the effect of oral antidiabetics upon isolated rat islets of Langerhans].
    Tjioe TO; Puchinger H; Wacker A
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):313-9. PubMed ID: 4911893
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhibition of the insulo-pancreatic response to intravenous glucose and tolbutamide administration during infusion of epinephrine].
    Laudicina E; Bompiani G; Angileri G; Mancuso L
    Folia Endocrinol; 1967 Apr; 20(2):154-63. PubMed ID: 4864821
    [No Abstract]   [Full Text] [Related]  

  • 25. A minimum of fuel is necessary for tolbutamide to mimic the effects of glucose on electrical activity in pancreatic beta-cells.
    Henquin JC
    Endocrinology; 1998 Mar; 139(3):993-8. PubMed ID: 9492030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Action of alkaloids from podophyllin on the response of pancreatic beta-cells of the rabbit to tolbutamide].
    Gónzalez Larriba JL; Picaporte MA; Grande C; Gasalla Chacón R; Montero García JM
    Rev Esp Oncol; 1983; 30(4):485-90. PubMed ID: 6400620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

  • 28. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term actions of sulfonylureas on (pro-)insulin biosynthesis and secretion. II. Studies after administration of tolbutamide and glibenclamide to rats in vivo.
    Schatz H; Laube H; Sieradzki J; Kamenisch W; Pfeiffer EF
    Horm Metab Res; 1978 Jan; 10(1):23-9. PubMed ID: 415958
    [No Abstract]   [Full Text] [Related]  

  • 30. [Morphology and histochemistry of insulin secretion].
    Creutzfelt W
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():387-416. PubMed ID: 4313827
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term actions of sulfonylureas on (Pro-) insulin biosynthesis and secretion. III. Functional state of isolated pancreatic rat islets after culture in the presence of tolbutamide and glibenclamide.
    Gonnermann B; Gustson D; Schatz H
    Horm Metab Res; 1981 Jul; 13(7):411-2. PubMed ID: 6792024
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 34. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets.
    Ishiyama N; Ravier MA; Henquin JC
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E540-9. PubMed ID: 16249257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
    Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
    Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural changes in islets of the rat produced by tolbutamide.
    WILLIAMSON JR; LACY PE; GRISHAM JW
    Diabetes; 1961; 10():460-9. PubMed ID: 14007249
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of i.v. tolbutamide on alpha- and beta-cell secretion in type I diabetes].
    Verga S; Donatelli M; Cerasola G; Sinagra D; Inglese CG; Terrizzi C
    Minerva Endocrinol; 1984; 9(3):339-42. PubMed ID: 6398400
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of sulfonylurea compounds on the mitosis frequency of islet beta cells].
    JORES J; KRACHT J
    Acta Endocrinol (Copenh); 1959 Oct; 32():243-54. PubMed ID: 14407899
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study in rats of the development of the islands of Langerhans under the effect of the chronic administration, separate or combined, of tolbutamide and diazoxide].
    Loubatières A; Mariani MM; Alric R; Houareau MH
    C R Seances Soc Biol Fil; 1968 Jul; 162(1):191-6. PubMed ID: 4236008
    [No Abstract]   [Full Text] [Related]  

  • 40. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
    Mariot P; Gilon P; Nenquin M; Henquin JC
    Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.